TGFβ blocks IFNα/β release and tumor rejection in spontaneous mammary tumors
Interferons have been shown to mediate tumour rejection. Here, in a spontaneous mouse model of breast cancer, the authors show that this is disrupted owing to high levels of TGFβ produced in the tumour.
Main Authors: | Marion V. Guerin, Fabienne Regnier, Vincent Feuillet, Lene Vimeux, Julia M. Weiss, Georges Bismuth, Gregoire Altan-Bonnet, Thomas Guilbert, Maxime Thoreau, Veronica Finisguerra, Emmanuel Donnadieu, Alain Trautmann, Nadège Bercovici |
---|---|
Format: | Article |
Language: | English |
Published: |
Nature Publishing Group
2019-09-01
|
Series: | Nature Communications |
Online Access: | https://doi.org/10.1038/s41467-019-11998-w |
Similar Items
-
Local IFNα enhances the anti-tumoral efficacy of systemic anti-PD1 to prevent tumor relapse
by: Maxime Thoreau, et al.
Published: (2020-07-01) -
The STING agonist DMXAA triggers a cooperation between T lymphocytes and myeloid cells that leads to tumor regression
by: Julia M. Weiss, et al.
Published: (2017-10-01) -
Preclinical murine tumor models: A structural and functional perspective
by: Marion V Guerin, et al.
Published: (2020-01-01) -
The Remarkable Plasticity of Macrophages: A Chance to Fight Cancer
by: Nadège Bercovici, et al.
Published: (2019-07-01) -
The Different Effects of IFN-β and IFN-γ on the Tumor-Suppressive Activity of Human Amniotic Fluid-Derived Mesenchymal Stem Cells
by: Jingchun Du, et al.
Published: (2019-01-01)